KILITCH DRUGS (INDIA) LTD. - 524500 - Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Mukund MehtaDesignation :- Managing Director / Whole Time Director KILITCH DRUGS (INDIA) LTD. - 524500 - Shareholding for the Period Ended September 30, 2021
Kilitch Drugs India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here KILITCH DRUGS (INDIA) LTD. - 524500 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Kilitch Drugs India Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Kilitch Drugs India Ltd - 524500 - Scrutinizer Report And Voting Results Of The 29Th Annual General Meeting Of The Company
The Company's 29th Annual General Meeting (AGM) was held on Wednesday, 29th September 2021 at 9:11 A.M through video conferencing or other audio visual means. In terms of the provisions of the Companies Act, 2013 and the Rules made thereunder and as per the provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company had provided remote E-voting facility to its members. Mr. Deep Shukla, Proprietor of M/s Deep Shukla and Associates, Company Secretaries was appointed as the Scrutinizer to scrutinize the voting conducted through remote e-voting for the AGM. The Scrutinizer's Report dated 30th September 2021, is attached as Annexure I. In terms of the provisions of Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the details of the results held through remote e-voting is attached herewith as Annexure II. Kilitch Drugs India Ltd - 524500 - Closure of Trading Window
This is to inform you that pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time read with NSE Circular Reference no. NSE/CML/2019/11 and BSE Circular Reference no. LIST/COMP/01/2019-20, both dated 2nd April 2019, Trading Window for dealing in Securities of the Company will remain closed for Designated Persons of the Company and their immediate relatives with effect from Friday, 1st October 2021 till 48 hours after the declaration of Financial Results of the Company for the Quarter ended 30th September 2021. The date of meeting of Board of Directors to approve the Financial Results of the Company for the quarter ended 30th September 2021 shall be informed in due course. KILITCH DRUGS (INDIA) LTD. - 524500 - Shareholder Meeting / Postal Ballot-Outcome of AGM
This is to inform you that the 29th Annual General Meeting of the members of Kilitch Drugs (India) Limited was held today i.e. Wednesday, September 29, 2021, through Video Conferencing (VC)/ Other Audio Visual Means (OAVM). In this regard, please find enclosed the proceedings as required under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. KILITCH DRUGS (INDIA) LTD. - 524500 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 read with 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith copies of newspaper advertisement published in the following newspapers on September 4, 2021 and September 5, 2021 with respect to the completion of dispatch of electronic copies of Notice of 29th Annual General Meeting of the Company and Annual Report FY2020-21 and information related to e-voting: 1.Free Press Journal- English Daily 2.Navshakti- Marathi Daily Kilitch Drugs India Ltd - 524500 - Reg. 34 (1) Annual Report
Pursuant to Regulation 34(1) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we enclose herewith the Notice of the 29th AGM and the Annual Report FY2020-21 of the Company, which is being sent today to the shareholders through electronic mode, whose email IDs are registered with the Company/ Depositories. The 29th AGM of the Company is scheduled to be held on Wednesday, September 29, 2021 at 9:00 a.m. (IST) through Video Conference (VC) or other Audio Visual Means (OAVM). AGM Notice and the Annual Report FY2020-21 are also made available on the Company's website: www.kilitch.com Details and instructions to attend, vote and view the proceedings of the 29th AGM has been provided in the 29th AGM Notice. KILITCH DRUGS (INDIA) LTD. - 524500 - Fixes Book Closure for AGM
Kilitch Drugs India Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 23, 2021 to September 29, 2021 (both days inclusive) for the purpose of 29th Annual General Meeting (AGM) of the Company to be held on September 29, 2021. KILITCH DRUGS (INDIA) LTD. - 524500 - Outcome Of Board Meeting Held On 13Th August 2021
In continuation to our letter dated 5th August 2021, we wish to inform you that pursuant to Regulation 33 and Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors of the company, at its meeting held today i.e. 13th August 2021, have considered and approved the following- 1.The Un-audited financial results of the company for the quarter ended 30th June 2021; In this connection please find enclosed the copy of Un-audited Standalone financial Results of the Company for the quarter ended 30th June 2021 along with Limited Review Report by the Statutory Auditors of the Company as 'Annexure-I'. 2.The appointment of M/s Suryaprakash Maurya & Co (FRN: 147410W) as the Statutory Auditor of the Company to hold office from the conclusion of 29th AGM till the conclusion of 34th AGM.